| Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway P Dvorak, L Chrast, PI Nikel, R Fedr, K Soucek, M Sedlackova, ... Microbial cell factories 14, 1-15, 2015 | 287 | 2015 |
| Alternative mechanisms of miR-34a regulation in cancer E Slabáková, Z Culig, J Remšík, K Souček Cell death & disease 8 (10), e3100-e3100, 2017 | 279 | 2017 |
| ZEB1: a critical regulator of cell plasticity, DNA damage response, and therapy resistance S Drápela, J Bouchal, MK Jolly, Z Culig, K Souček Frontiers in molecular biosciences 7, 36, 2020 | 142 | 2020 |
| TGF‐β1‐induced EMT of non‐transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug E Slabáková, Z Pernicová, E Slavíčková, A Staršíchová, A Kozubík, ... The prostate 71 (12), 1332-1343, 2011 | 108 | 2011 |
| The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques L Vistejnova, J Dvorakova, M Hasova, T Muthny, V Velebny, K Soucek, ... Neuroendocrinology Letters 30 (1), 121, 2009 | 103 | 2009 |
| Normal and prostate cancer cells display distinct molecular profiles of α‐tubulin posttranslational modifications K Souček, A Kamaid, AD Phung, L Kubala, JC Bulinski, RW Harper, ... The Prostate 66 (9), 954-965, 2006 | 101 | 2006 |
| Trop2: Jack of all trades, master of none S Lenárt, P Lenárt, J Šmarda, J Remšík, K Souček, P Beneš Cancers 12 (11), 3328, 2020 | 100 | 2020 |
| Growth/differentiation factor-15: prostate cancer suppressor or promoter? P Vaňhara, A Hampl, A Kozubík, K Souček Prostate cancer and prostatic diseases 15 (4), 320-328, 2012 | 92 | 2012 |
| High effectiveness of platinum (IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro A Kozubík, V Horváth, L Švihálková-Šindlerová, K Souček, J Hofmanová, ... Biochemical pharmacology 69 (3), 373-383, 2005 | 86 | 2005 |
| The fibroblast surface markers FAP, anti‐fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial‐to‐mesenchymal transition Z Kahounová, D Kurfürstová, J Bouchal, G Kharaishvili, J Navrátil, ... Cytometry Part A 93 (9), 941-951, 2018 | 84 | 2018 |
| Inhibition of topoisomerase IIα: novel function of wedelolactone P Benes, L Knopfova, F Trcka, A Nemajerova, D Pinheiro, K Soucek, ... Cancer letters 303 (1), 29-38, 2011 | 77 | 2011 |
| Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells R Jendželovský, J Mikeš, K Souček, J Procházková, M Kello, V Sačková, ... Photochemical & Photobiological Sciences 8 (12), 1716-1723, 2009 | 77 | 2009 |
| c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis L Knopfová, P Beneš, L Pekarčíková, M Hermanová, M Masařík, ... Molecular cancer 11, 1-15, 2012 | 73 | 2012 |
| Rottlerin Inhibits ROS Formation and Prevents NFκB Activation in MCF‐7 and HT‐29 Cells E Maioli, L Greci, K Soucek, M Hyzdalova, A Pecorelli, V Fortino, ... BioMed Research International 2009 (1), 742936, 2009 | 71* | 2009 |
| Effect of apple extracts on NF-κB activation in human umbilical vein endothelial cells PA Davis, JA Polagruto, G Valacchi, A Phung, K Soucek, CL Keen, ... Experimental Biology and Medicine 231 (5), 594-598, 2006 | 63 | 2006 |
| T umor suppressor candidate 3 (TUSC3) prevents the epithelial‐to‐mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in … K Kratochvílová, P Horak, M Ešner, K Souček, D Pils, M Anees, ... International journal of cancer 137 (6), 1330-1340, 2015 | 58 | 2015 |
| Furo[3,2‐b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway V Němec, M Hylsová, L Maier, J Flegel, S Sievers, S Ziegler, M Schröder, ... Angewandte Chemie International Edition 58 (4), 1062-1066, 2019 | 57 | 2019 |
| Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands E Hrubá, J Vondráček, H Líbalová, J Topinka, V Bryja, K Souček, ... Toxicology letters 206 (2), 178-188, 2011 | 55 | 2011 |
| Growth/differentiation factor-15 inhibits differentiation into osteoclasts—A novel factor involved in control of osteoclast differentiation P Vaňhara, E Lincová, A Kozubík, P Jurdic, K Souček, J Šmarda Differentiation 78 (4), 213-222, 2009 | 54 | 2009 |
| Toll-like receptor 3 in solid cancer and therapy resistance XM Muresan, J Bouchal, Z Culig, K Souček Cancers 12 (11), 3227, 2020 | 52 | 2020 |
